In support of an early intensive treatment of type 2 diabetes and not necessarily of early polypharmacy.
L
L
Czupryniak
E
E
Szymańska-Garbacz
M
M
Pawłowski
M
M
Saryusz-Wolska
J
J
Loba
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D054795:Incretins / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use*; D008297:Male
D007004:Hypoglycemic Agents; D000960:Hypolipidemic Agents; D054795:Incretins; D007328:Insulin